Chloroquine versus amodiaquine in the treatment of Plasmodium falciparum malaria in northeast India.
Artículo
en Inglés
| IMSEAR
| ID: sea-23047
ABSTRACT
Amodiaquine is being used in India for presumptive treatment as an alternative to chloroquine in areas with chloroquine resistant P. falciparum. Keeping in view the toxicity of amodiaquine, studies have been undertaken to evaluate the advantage of the drug over chloroquine in the treatment of P. falciparum malaria. In vivo drug resistance studies were carried out in the states of Assam and Meghalaya in India. A total of 388 subjects have been studied to compare the efficacy of chloroquine and amodiaquine. The overall cure rate, degree of resistance, mean parasite clearance time and mean parasite recrudescence time were comparable for both the drugs, the differences being not statistically significant. The results indicate no advantage of amodiaquine in the treatment of patients with P. falciparum infection in chloroquine resistant areas of northeast India and development of cross resistance in P. falciparum to these 4-aminoquinolines is complete and parallel.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Anciano
/
Femenino
/
Humanos
/
Masculino
/
Niño
/
Preescolar
/
Cloroquina
/
Adolescente
/
Malaria Falciparum
/
Adulto
Tipo de estudio:
Ensayo Clínico Controlado
País/Región como asunto:
Asia
Idioma:
Inglés
Año:
1995
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS